LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Aciont

Non-invasive, controlled, and sustained release back-of-the-eye therapeutics for sight-threatening diseases such as: severe uveitis, diabetic macular....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Aciont plus 6116 other startups.

Learn More About Aciont

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More